AXSM Axsome Therapeutics Inc tops Q4 2025 earnings estimates and posts 655 percent year over year revenue growth LRMR Larimar Therapeutics Q4 loss widens 41 miss as drug development costs climb shares edge lower Nutex Health NUTX Stock Sentiment Analysis 375 20260418 Array UZF Stock Analysis Flat at 1773 Whats Next 20260520 Travelers Companies TRV Holds Steady Near 307 as Resilience Tested My Size MYSZ Climbs 275 Resistance at 055 in Focus 20260520 VAALCO Energy EGY Slips 159 as Shares Test Key Support Near 542